Comparison of therapeutic efficacy of lipo-doxorubicin and doxorubicin in treating bladder cancer
Objectives: Doxorubicin is commonly used in the treatment of superficial bladder cancer, but more side effects and shorter intracellular retention time hamper its clinical application. Since lipo-doxorubicin (Lipodox) has the advantages of longer half-life and lower clearance rate than doxorubicin,...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2017-12-01
|
| Series: | Urological Science |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1879522616303839 |